Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted hydrindanes for the treatment of angiogenesis-dependent diseases

Substituted hydrindanes for the treatment of angiogenesis-dependent diseases

US Patent 5686621 · Granted Nov 11, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Devices, systems, and methods for modeling ocular translaminar pressure gradient2023
Transferrin/transferrin receptor-mediated siRNA delivery2018
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions2017
Transferrin/transferrin receptor-mediated siRNA delivery2017
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma2017
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions2016
RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular a2016
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions2015
RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular a2015
Transferrin/transferrin receptor-mediated siRNA delivery2015
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma2015
RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma2014